Diagnos Inc. DGNOF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -36.63% | -47.75% | -50.04% | -48.63% | -40.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.63% | -47.75% | -50.04% | -48.63% | -40.68% |
| Cost of Revenue | -45.21% | -48.13% | -58.00% | -63.19% | -92.19% |
| Gross Profit | -6.67% | 48.21% | 59.56% | 66.36% | 102.65% |
| SG&A Expenses | -2.39% | 26.22% | 50.50% | 65.17% | 56.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.50% | 32.44% | 47.46% | 56.24% | 36.44% |
| Operating Income | -12.81% | -35.64% | -52.79% | -62.97% | -41.47% |
| Income Before Tax | -7.40% | -22.92% | -37.82% | -47.09% | -32.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.40% | -22.92% | -37.82% | -47.09% | -32.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.40% | -22.92% | -37.82% | -47.09% | -32.65% |
| EBIT | -12.81% | -35.64% | -52.79% | -62.97% | -41.47% |
| EBITDA | -13.92% | -37.73% | -54.97% | -65.65% | -43.07% |
| EPS Basic | 10.76% | 2.42% | -7.19% | -16.34% | -8.18% |
| Normalized Basic EPS | 12.39% | 1.93% | -8.50% | -17.80% | -10.10% |
| EPS Diluted | 10.76% | 2.42% | -7.19% | -16.34% | -8.18% |
| Normalized Diluted EPS | 12.39% | 1.93% | -8.50% | -17.80% | -10.10% |
| Average Basic Shares Outstanding | 22.00% | 27.81% | 28.74% | 26.42% | 21.17% |
| Average Diluted Shares Outstanding | 22.00% | 27.81% | 28.74% | 26.42% | 21.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |